FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014486875> ?p ?o ?g. }

• W2014486875 endingPage "1187" @default.
• W2014486875 startingPage "1179" @default.
• W2014486875 abstract "ObjectiveExtracorporeal life support is used in 3% to 8% of infants and children after cardiac surgery. B-type natriuretic peptide may have utility as a biomarker in these patients. The objective of this study was to investigate potential associations between changes in B-type natriuretic peptide during trials off extracorporeal life support and clinical outcome.MethodsTen infants and children requiring extracorporeal life support after cardiac surgery were studied prospectively. Before separation from extracorporeal life support, a shunt was placed in the circuit, allowing for temporary trials off life support. Serum lactate, arterial–venous oxyhemoglobin saturation difference, and B-type natriuretic peptide levels were determined before each trial off life support and at the end of each trial off life support, and the ability to predict postoperative outcome from these data was evaluated.ResultsDuring trials off extracorporeal life support, lactate, the arterial–venous oxyhemoglobin saturation difference, and B-type natriuretic peptide levels increased above pre-trial values (P < .05). Only the arterial–venous oxyhemoglobin saturation difference predicted successful separation from extracorporeal life support after a trial (P < .05). There were no associations between long-term outcome and alterations in lactate and the arterial–venous oxyhemoglobin saturation difference during the final trials off life support. However, an increase in B-type natruiretic peptide levels during the final trial off life support (trial/pre-trial ratio of >1) had a sensitivity of 80% and a specificity of 100% for predicting the need for an unplanned operation or death within 3 months (P < .05).ConclusionB-type natriuretic peptide determinations may be a useful tool for clinicians caring for infants and children requiring extracorporeal life support after cardiac surgery. Extracorporeal life support is used in 3% to 8% of infants and children after cardiac surgery. B-type natriuretic peptide may have utility as a biomarker in these patients. The objective of this study was to investigate potential associations between changes in B-type natriuretic peptide during trials off extracorporeal life support and clinical outcome. Ten infants and children requiring extracorporeal life support after cardiac surgery were studied prospectively. Before separation from extracorporeal life support, a shunt was placed in the circuit, allowing for temporary trials off life support. Serum lactate, arterial–venous oxyhemoglobin saturation difference, and B-type natriuretic peptide levels were determined before each trial off life support and at the end of each trial off life support, and the ability to predict postoperative outcome from these data was evaluated. During trials off extracorporeal life support, lactate, the arterial–venous oxyhemoglobin saturation difference, and B-type natriuretic peptide levels increased above pre-trial values (P < .05). Only the arterial–venous oxyhemoglobin saturation difference predicted successful separation from extracorporeal life support after a trial (P < .05). There were no associations between long-term outcome and alterations in lactate and the arterial–venous oxyhemoglobin saturation difference during the final trials off life support. However, an increase in B-type natruiretic peptide levels during the final trial off life support (trial/pre-trial ratio of >1) had a sensitivity of 80% and a specificity of 100% for predicting the need for an unplanned operation or death within 3 months (P < .05). B-type natriuretic peptide determinations may be a useful tool for clinicians caring for infants and children requiring extracorporeal life support after cardiac surgery." @default.
• W2014486875 created "2016-06-24" @default.
• W2014486875 creator A5008401043 @default.
• W2014486875 creator A5009546461 @default.
• W2014486875 creator A5012836327 @default.
• W2014486875 creator A5020384406 @default.
• W2014486875 creator A5029191837 @default.
• W2014486875 creator A5038882859 @default.
• W2014486875 creator A5047914925 @default.
• W2014486875 creator A5050405747 @default.
• W2014486875 date "2007-11-01" @default.
• W2014486875 modified "2023-09-23" @default.
• W2014486875 title "B-type natriuretic peptide levels predict outcomes for children on extracorporeal life support after cardiac surgery" @default.
• W2014486875 cites W1967208670 @default.
• W2014486875 cites W1980879874 @default.
• W2014486875 cites W2001401679 @default.
• W2014486875 cites W2004723537 @default.
• W2014486875 cites W2019337977 @default.
• W2014486875 cites W2022651264 @default.
• W2014486875 cites W2032368919 @default.
• W2014486875 cites W2036256407 @default.
• W2014486875 cites W2039685273 @default.
• W2014486875 cites W2041665090 @default.
• W2014486875 cites W2050565648 @default.
• W2014486875 cites W2063209688 @default.
• W2014486875 cites W2063889021 @default.
• W2014486875 cites W2070341655 @default.
• W2014486875 cites W2071787670 @default.
• W2014486875 cites W2081616757 @default.
• W2014486875 cites W2089985255 @default.
• W2014486875 cites W2090094408 @default.
• W2014486875 cites W2091809227 @default.
• W2014486875 cites W2104411063 @default.
• W2014486875 cites W2114587126 @default.
• W2014486875 cites W2119853884 @default.
• W2014486875 cites W2120561016 @default.
• W2014486875 cites W2121708608 @default.
• W2014486875 cites W2131473848 @default.
• W2014486875 cites W2138373808 @default.
• W2014486875 cites W2144358802 @default.
• W2014486875 cites W2144746349 @default.
• W2014486875 cites W2150359689 @default.
• W2014486875 cites W2151502860 @default.
• W2014486875 cites W2161506275 @default.
• W2014486875 cites W2164868853 @default.
• W2014486875 cites W2166410110 @default.
• W2014486875 cites W2169429079 @default.
• W2014486875 doi "https://doi.org/10.1016/j.jtcvs.2007.04.023" @default.
• W2014486875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17976447" @default.
• W2014486875 hasPublicationYear "2007" @default.
• W2014486875 type Work @default.
• W2014486875 sameAs 2014486875 @default.
• W2014486875 citedByCount "18" @default.
• W2014486875 countsByYear W20144868752012 @default.
• W2014486875 countsByYear W20144868752013 @default.
• W2014486875 countsByYear W20144868752014 @default.
• W2014486875 countsByYear W20144868752022 @default.
• W2014486875 crossrefType "journal-article" @default.
• W2014486875 hasAuthorship W2014486875A5008401043 @default.
• W2014486875 hasAuthorship W2014486875A5009546461 @default.
• W2014486875 hasAuthorship W2014486875A5012836327 @default.
• W2014486875 hasAuthorship W2014486875A5020384406 @default.
• W2014486875 hasAuthorship W2014486875A5029191837 @default.
• W2014486875 hasAuthorship W2014486875A5038882859 @default.
• W2014486875 hasAuthorship W2014486875A5047914925 @default.
• W2014486875 hasAuthorship W2014486875A5050405747 @default.
• W2014486875 hasBestOaLocation W20144868751 @default.
• W2014486875 hasConcept C126322002 @default.
• W2014486875 hasConcept C164705383 @default.
• W2014486875 hasConcept C168563851 @default.
• W2014486875 hasConcept C177713679 @default.
• W2014486875 hasConcept C2775846464 @default.
• W2014486875 hasConcept C2775915353 @default.
• W2014486875 hasConcept C2778198053 @default.
• W2014486875 hasConcept C2778789114 @default.
• W2014486875 hasConcept C2779915274 @default.
• W2014486875 hasConcept C2780409771 @default.
• W2014486875 hasConcept C2994232697 @default.
• W2014486875 hasConcept C42219234 @default.
• W2014486875 hasConcept C535046627 @default.
• W2014486875 hasConcept C71924100 @default.
• W2014486875 hasConceptScore W2014486875C126322002 @default.
• W2014486875 hasConceptScore W2014486875C164705383 @default.
• W2014486875 hasConceptScore W2014486875C168563851 @default.
• W2014486875 hasConceptScore W2014486875C177713679 @default.
• W2014486875 hasConceptScore W2014486875C2775846464 @default.
• W2014486875 hasConceptScore W2014486875C2775915353 @default.
• W2014486875 hasConceptScore W2014486875C2778198053 @default.
• W2014486875 hasConceptScore W2014486875C2778789114 @default.
• W2014486875 hasConceptScore W2014486875C2779915274 @default.
• W2014486875 hasConceptScore W2014486875C2780409771 @default.
• W2014486875 hasConceptScore W2014486875C2994232697 @default.
• W2014486875 hasConceptScore W2014486875C42219234 @default.
• W2014486875 hasConceptScore W2014486875C535046627 @default.
• W2014486875 hasConceptScore W2014486875C71924100 @default.
• W2014486875 hasIssue "5" @default.
• W2014486875 hasLocation W20144868751 @default.
• W2014486875 hasLocation W20144868752 @default.

• next